#USA #Valencia #Valencia Technologies #eCoin #Richard Klauer

Valencia Technologies Expands Leadership with Richard W. Klauer

Valencia Technologies is making significant strides in the urology market by appointing Richard W. Klauer as their new Vice President of Sales. This move is part of a broader strategy to enhance their commercial organization, focusing on increasing sales and improving customer support for their innovative eCoin® system, which aims to treat urgency urinary incontinence (UUI).

Who is Richard W. Klauer?

Richard W. Klauer brings a wealth of experience to his new role, with over 20 years dedicated to medical device sales concentrated in urology. Having a proven track record across various urological specializations, Klauer has effectively led sales teams in companies that have developed groundbreaking technologies improving patient care outcomes. His experience in navigating complex healthcare markets will be vital as Valencia Technologies seeks to build new partnerships and expand its market share.

Focus on eCoin® System

At Valencia, Klauer's main objective will be to foster the commercial adoption of the eCoin system—a revolutionary product designed to assist individuals suffering from UUI. In his own words, Klauer expressed his enthusiasm: "I am excited to continue my career in the urology space with such an innovative company as Valencia. We look forward to expanding access to eCoin for the many physicians and patients across the country who seek another treatment option."

The eCoin device is remarkable for its size; it is a coin-sized neurostimulator implanted subcutaneously near the ankle through a minimally invasive outpatient procedure. This system is engineered to automatically deliver stimulation to the tibial nerve, operating twice weekly without requiring any complicated patient management. In pivotal clinical studies, the eCoin has demonstrated its effectiveness, showing a 50% reduction in urgency urinary incontinence episodes in 75% of participants after one year of treatment.

Enhancing Patient Experience

One of the standout features of the eCoin system is its streamlined post-implant experience. Unlike many existing stimulation devices that demand frequent recharging or complicated patient programming, most users of the eCoin need only a single post-implant programming session. This simplicity minimizes disruption and enhances quality of life for those treated—allowing patients to maintain their daily routines without additional burdens.

Valencia Technologies: Pioneering Urology Solutions

Founded and headquartered in Valencia, California, Valencia Technologies is a pioneer in the medical device arena focused on minimally invasive treatments for conditions like urinary incontinence. The eCoin system is noted as the first and only FDA-approved, subcutaneous implantable tibial nerve stimulator for UUI, a significant benchmark in the field. Valencia’s vision extends toward making most eCoin implant procedures accessible at clinic settings, thereby enhancing patient convenience and care quality.

With Klauer on board and a clear strategy in place, Valencia Technologies is poised for a growth spurt in the urology market while remaining committed to patient-centered care. This leadership expansion aligns with their mission to enhance accessibility to innovative treatment options, transforming the landscape of urological care for patients seeking solutions for urgency urinary incontinence.

For more information about Valencia Technologies and the eCoin system, visit www.valenciatechnologies.com.